Evogene Ltd.
EVGN- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- SEC CIK
- 0001574565
In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Evogene Ltd. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 18 | 15 | −3 |
| Shares | 181.7K | 530.6K | +348.9K (+192.0%) |
| Value | $199.8K | $408.9K | +$209.0K (+104.6%) |
New holders (2)
Institutions that held Evogene Ltd. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 456,587 | $351.6K | 0.01% |
| Two Sigma Securities, LLC | 12,465 | $9.60K | 0.00% |
Sold out (5)
Institutions that held Evogene Ltd. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Citadel Advisors LLC | 88,764 | $97.6K |
| Altshuler Shaham Ltd | 750 | $825 |
| Bank of America Corp | 159 | $175 |
| Russell Investments Group, Ltd. | 1 | $1 |
| Farther Finance Advisors, LLC | 1 | $1 |